scispace - formally typeset
Open AccessJournal ArticleDOI

Estudio multicéntrico de prevalencia de hiperglucemia en pacientes hospitalizados con nutrición parenteral

Reads0
Chats0
TLDR
This national multicentric study of the prevalence of hyperglycemia among patients with parenteral nutrition, leaded by hospital pharmacists, was a joint effort aimed to better understand this metabolic complication.
About
This article is published in Farmacia Hospitalaria.The article was published on 2006-01-01 and is currently open access. It has received 18 citations till now. The article focuses on the topics: Parenteral nutrition.

read more

Citations
More filters
Journal ArticleDOI

Recommendations of the GARIN group for managing non-critically ill patients with diabetes or stress hyperglycaemia and artificial nutrition

TL;DR: The best drug treatment for treating hyperglycaemia/diabetes in hospitalised patients is insulin and the GARIN working group makes recommendations for adapt the theoretical insulin action to the nutrition infusion regimen.
Journal ArticleDOI

Study of hyperglycemia in non critically-ill patients receiving parenteral nutrition: incidence and risk factors

TL;DR: Glucose administration in non-critically ill patients receiving parenteral nutrition should be reassessed downwards, especially in the immediate postsurgery, renal impairment and in patients treated with somatostatin analogues.
Journal ArticleDOI

Renal consequences of parenteral nutrition.

TL;DR: Adequate clinical and biochemical assessment and monitoring of children receiving parenteral nutrition by a multidisciplinary nutrition support team is recommended to mitigate against the risks of these complications.
Journal ArticleDOI

Soporte nutricional con nutrición parenteral. Evolución y complicaciones asociadas

TL;DR: In this article, caracteristicas clinicas de los pacientes that have recibido nutricion parenteral (NP) in a hospital of 420 camas were described.
References
More filters
Journal ArticleDOI

Intensive Insulin Therapy in Critically Ill Patients

TL;DR: Intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit.
Journal ArticleDOI

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.

TL;DR: Normoglycemia was safely reached within 24 hrs and maintained during intensive care by using insulin titration guidelines, and metabolic control, as reflected by normoglycesmia, rather than the infused insulin dose per se, was related to the beneficial effects of intensive insulin therapy.
Journal ArticleDOI

Glucose Control and Mortality in Critically Ill Patients

TL;DR: Increased insulin administration is positively associated with death in the ICU regardless of the prevailing blood glucose level, and control of glucose levels rather than of absolute levels of exogenous insulin appear to account for the mortality benefit associated with intensive insulin therapy demonstrated by others.
Journal ArticleDOI

Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation

TL;DR: Oral mucositis is associated with significantly worse clinical and economic outcomes in blood and marrow transplantation and was significantly correlated with all of the outcomes of interest except days with fever.
Journal ArticleDOI

Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose

TL;DR: TPN dextrose infusion rate was positively correlated with blood glucose concentration, over and above other variables considered in a multiple regression, including kcal/kg administered, furosemide or dopamine use, gender, age, or diagnosis.
Related Papers (5)